Imunon, Inc.
CLSN
Kedudukan dalam Saham
#34949
Imunon, Inc. is a biotechnology firm in the clinical development stage,... Imunon, Inc. is a biotechnology firm in the clinical development stage, dedicated to innovating and commercializing DNA-centric immunotherapies, vaccines, and targeted chemotherapy solutions. Its primary pipeline assets include GEN-1, a DNA-based immunotherapy specifically designed for the localized treatment of ovarian cancer, and ThermoDox, a unique formulation of doxorubicin encapsulated in heat-activated liposomes, currently being assessed for a variety of cancer indications. Furthermore, the company is advancing two early-phase platform technologies aimed at developing nucleic acid-based immunotherapies, vaccines, and other anti-cancer DNA or RNA treatments. Established in 1982, Imunon, Inc. maintains its operational base in Lawrenceville, New Jersey.
Harga Saham
$1.96
Disegerakkan terakhir: 2022-09-20
Modal Pasaran
$4.46M
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
122.70%
Negara
US
Perdagangan Imunon, Inc. (CLSN)
Kategori
Healthcare
Sejarah pecahan saham untuk Imunon, Inc. (CLSN)
Saham Imunon, Inc. (simbol: CLSN) telah mengalami sejumlah 0 pecahan saham.
Pecahan saham terkini berlaku pada Oct 21, 2026.
Satu saham CLSN yang dibeli sebelum Oct 21, 2026 kini bersamaan dengan 0 saham CLSN.
Pecahan saham terkini berlaku pada Oct 21, 2026.
Satu saham CLSN yang dibeli sebelum Oct 21, 2026 kini bersamaan dengan 0 saham CLSN.
Senarai pecahan saham
| Tahun | Pecahan | Gandaan | Gandaan Kumulatif |
|---|---|---|---|
| Tidak cukup data untuk tarikh yang disediakan. | |||
Pecahan saham untuk syarikat pesaing atau serupa
| Syarikat | Bilangan pecahan saham | Gandaan Kumulatif | Negara |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
